PainReform Ltd. Depreciation & Amortization 2011-2026 | PRFX

Annual Depreciation & Amortization PainReform Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15 K	16 K	15 K	15 K	7 K	-	1 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16 K	1 K	11.5 K

Quarterly Depreciation & Amortization PainReform Ltd.

2025-Q4	2025-Q2	2024-Q4	2024-Q2	2023-Q4	2023-Q2	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
15 K	9 K	16 K	8 K	15 K	6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16 K	6 K	11.5 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.14	0.74 %	$ 895 M	USA
Anika Therapeutics ANIK	6.43 M	$ 14.74	-0.2 %	$ 216 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.63	3.5 %	$ 434 M	Britain
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.13	-0.48 %	$ 651 M	USA
Exelixis EXEL	29.1 M	$ 49.35	2.47 %	$ 13.4 B	USA
Fortress Biotech FBIO	403 K	$ 2.36	-1.26 %	$ 65.8 M	USA
Forte Biosciences FBRX	64 K	$ 24.9	3.65 %	$ 322 M	USA
AbbVie ABBV	762 M	$ 203.32	0.97 %	$ 360 B	USA
Gilead Sciences GILD	370 M	$ 133.2	1.42 %	$ 166 B	USA
Compugen Ltd. CGEN	461 K	$ 2.82	-2.76 %	$ 263 M	Israel
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 0.77	0.16 %	$ 35.2 M	Israel
ACADIA Pharmaceuticals ACAD	920 K	$ 22.41	0.04 %	$ 3.71 B	USA
Genprex GNPX	6.69 K	$ 0.85	-1.99 %	$ 793 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.46	-1.98 %	$ 5.7 M	Israel
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 21.09	-0.4 %	$ 2.68 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA